Wuping Yang1,2,3,4, Kenan Zhang1,2,3,4, Lei Li1,2,3,4, Yawei Xu1,2,3,4, Kaifang Ma1,2,3,4, Haibiao Xie1,2,3,4, Jingcheng Zhou1,2,3,4, Lin Cai1,2,3,4, Yanqing Gong5,6,7,8, Kan Gong9,10,11,12. 1. Department of Urology, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China. 2. Hereditary Kidney Cancer Research Center, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China. 3. Institute of Urology, Peking University, Beijing, 100034, People's Republic of China. 4. National Urological Cancer Center, Beijing, 100034, People's Republic of China. 5. Department of Urology, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China. yqgong@bjmu.edu.cn. 6. Hereditary Kidney Cancer Research Center, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China. yqgong@bjmu.edu.cn. 7. Institute of Urology, Peking University, Beijing, 100034, People's Republic of China. yqgong@bjmu.edu.cn. 8. National Urological Cancer Center, Beijing, 100034, People's Republic of China. yqgong@bjmu.edu.cn. 9. Department of Urology, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China. gongkan_pku@126.com. 10. Hereditary Kidney Cancer Research Center, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China. gongkan_pku@126.com. 11. Institute of Urology, Peking University, Beijing, 100034, People's Republic of China. gongkan_pku@126.com. 12. National Urological Cancer Center, Beijing, 100034, People's Republic of China. gongkan_pku@126.com.
Correction to: J Exp Clin Cancer Res 40, 92 (2021)https://doi.org/10.1186/s13046-021-01889-8Following publication of the original article [1], the authors identified a minor error in image-typesetting in Fig. 4, specifically:
Fig. 4
ZNF582-AS1 overexpression inhibited cell migratory and invasive ability in vitro and in vivo. a and b Wound healing assay determined the migratory distances of ZNF582-AS1-overexpressed OSRC2 and Caki-1 cells and their control cells. c and d Transwell migration and e and f invasion assays determined the migratory and invasive abilities of ZNF582-AS1-overexpressed OSRC2 and Caki-1 cells and their control cells. g and h The luciferase signals in the ZNF582-AS1-overexpressed group were remarkably lower than those in the control group. i There was no significant difference between the mice weight of ZNF582-AS1-overexpressed and control group. j and k The number and size of pulmonary metastases in the ZNF582-AS1-overexpressed group were significantly reduced compared with those in the control group. l and m ZNF582-AS1 overexpression increased Ecadherin expression and decreased N-cadherin expression in pulmonary metastases
Figure 4j: the first mouse lung of ZNF582-AS1 OE group has been replaced with the correct imageThe corrected figure is given below. The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.ZNF582-AS1 overexpression inhibited cell migratory and invasive ability in vitro and in vivo. a and b Wound healing assay determined the migratory distances of ZNF582-AS1-overexpressed OSRC2 and Caki-1 cells and their control cells. c and d Transwell migration and e and f invasion assays determined the migratory and invasive abilities of ZNF582-AS1-overexpressed OSRC2 and Caki-1 cells and their control cells. g and h The luciferase signals in the ZNF582-AS1-overexpressed group were remarkably lower than those in the control group. i There was no significant difference between the mice weight of ZNF582-AS1-overexpressed and control group. j and k The number and size of pulmonary metastases in the ZNF582-AS1-overexpressed group were significantly reduced compared with those in the control group. l and m ZNF582-AS1 overexpression increased Ecadherin expression and decreased N-cadherin expression in pulmonary metastases
Authors: Wuping Yang; Kenan Zhang; Lei Li; Yawei Xu; Kaifang Ma; Haibiao Xie; Jingcheng Zhou; Lin Cai; Yanqing Gong; Kan Gong Journal: J Exp Clin Cancer Res Date: 2021-03-10